[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344281-105":59,"doc-detail-344281-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","susceptibility-of-mitophagy-deficient-tumors-to-ferroptosis-induction-by-relieving-the-suppression-of-lipid-peroxidation","Susceptibility of Mitophagy-Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid Peroxidation","","Identification of ferroptosis-sensitive cancers is essential for effective ferroptosis-inducing therapy. Using patient-derived organoid screening models for colorectal cancer, the study shows that tumors with mitophagy deficiency are hypersensitive to ferroptosis induction. The work identifies a lipid-peroxidation negative feedback pathway as an intrinsic anti-ferroptosis mechanism. Mitophagy restricts lipid-peroxidation product formation and limits mitochondrial ROS accumulation, thereby blocking ferroptosis. Mitophagy-deficient tumors lack this protection, enabling strong ferroptotic death and selective inhibition of growth and distant metastasis under several therapeutic triggers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/susceptibility-of-mitophagy-deficient-tumors-to-ferroptosis-induction-by-relieving-the-suppression-of-lipid-peroxidation/344281/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/susceptibility-of-mitophagy-deficient-tumors-to-ferroptosis-induction-by-relieving-the-suppression-of-lipid-peroxidation/344281.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What model was used to identify ferroptosis-sensitive colorectal tumors?","Question",{"text":112,"@type":113},"Patient-derived organoid (PDO) screening models based on colorectal cancer tissues were established to identify tumors sensitive to ferroptosis-inducing therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does mitophagy deficiency affect ferroptosis sensitivity?",{"text":117,"@type":113},"Mitophagy-deficient tumors are hypersensitive to ferroptosis-inducing therapies because they lack an anti-ferroptotic mechanism that normally restrains lipid peroxidation and mitochondrial ROS accumulation.",{"name":119,"@type":110,"acceptedAnswer":120},"Which therapies were reported to trigger ferroptotic cell death in mitophagy-deficient tumors?",{"text":121,"@type":113},"Ferroptosis-inducing triggers include erastin, RSL3, cysteine deprivation, radiotherapy, and immunotherapy, which produce potent ferroptotic cell death in mitophagy-deficient tumors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344281,1790627488,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","RESEARCH ARTICLE  \n[www.advancedscience.com](www.advancedscience.com)  \nSusceptibility of Mitophagy-Deﬁcient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid Peroxidation  \nShan Liu, Jing-Hong Chen, Li-Chao Li, Zhi-Peng Ye, Jian-Nan Liu, Yu-Hong Chen, Bing-Xin Hu, Jia-Hong Tang, Gong-Kan Feng, Zhi-Ming Li, Chu-Xia Deng, Rong Deng, Xiao-Feng Zhu,* and Hai-Liang Zhang*  \nThe identiﬁcation offerroptosis-sensitive cancers is critical for the application offerroptosis-inducing therapies in cancer therapy. Here, patient-derived organoid screening models of colorectal cancer are established to  \nidentify tumors that are sensitive to ferroptosis-inducing therapy. This study discovers that patient-derived tumors characterized by mitophagy deﬁciencyare hypersensitive to ferroptosis-inducing therapies. Mechanistically, a novel negative feedback regulatory pathway of lipid peroxidation is identiﬁed, which is one of the important intrinsic anti-ferroptosis mechanisms of cancer cells. Lipid peroxidation-mediated endoplasmic reticulum stress transcriptionally upregulates Parkin to promote mitophagy through ATF4. Mitophagy limits the generation of lipid peroxidation products and subsequently inhibits ferroptosis by inhibiting the accumulation of mitochondrial ROS. Mitophagy-deﬁcient tumors lack this anti-ferroptotic mechanism, unleashing the generation of lipid peroxidation and potent ferroptotic cell death induced by erastin, RSL3, cysteine deprivation, radiotherapy, and immunotherapy. More importantly, ferroptosisinducing therapy selectively inhibits the growth and distant metastasis of mitophagy-deﬁcient tumors in vivo. In summary, patient-derived organoids of colorectal cancer patients for screening ferroptosis-sensitive tumors are established, providing a paradigm for identifying that patient-derived tumors are sensitive to ferroptosis-inducing therapies. This study concludes that mitophagydeﬁcient tumors are vulnerable to ferroptosis induction, which may lead to the development of new therapeutic strategies for tumors deﬁcient in mitophagy.  \n1. Introduction  \nFerroptosis is an iron-dependent form of programmed cell death driven by lipid peroxidation. [1,2] Ferroptosis inhibits the occurrence and development of tumorsand promotes the curative eﬀect of cancer therapy.[1,3,4] The induction offerroptosis is a promising antitumor strategy. However, the high heterogeneity of the sensitivity of tumors to ferroptosis greatly limits current translational research on ferroptosisinducing therapies. The identiﬁcation offerroptosis-sensitive tumors is critical for the application offerroptosis-inducing therapies in cancer. Patient-derived organoids (PDOs) are 3D cell clusters obtained from patient tumor tissues through 3D culture in vitro and play an important role in new drug screening and drug sensitivity studies. [5–8]  \nMitochondrial homeostasis consists of the synthesis and degradation of mitochondria and plays an important role in the malignant progression of tumors. [9] Our previous study revealed that defects in mitochondrial degradation, that is, defects in mitophagy, promote the malignant progression of breast cancer. [10] We found that mitophagy deﬁciency mediated by the low  \nS. Liu, L.-C. Li, Z.-P. Ye, Y.-H. Chen, B.-X. Hu, J.-H. Tang, G.-K. Feng,  \nZ.-M. Li, R. Deng, X.-F. Zhu, H.-L. Zhang  \nState Key Laboratory of Oncology in South China  \nGuangdong Provincial Clinical Research Center for Cancer  \nGuangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy  \nSun Yat-sen University Cancer Center  \nGuangzhou 510060, China  \nE-mail: [zhuxfeng@mail.sysu.edu.cn](zhuxfeng@mail.sysu.edu.cn); [zhanghl@sysucc.org.cn](zhanghl@sysucc.org.cn)  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202412593](https://doi.org/10.1002/advs.202412593)[ ](https://doi.org/10.1002/advs.202412593)© 2024 The Author(s). Advanced Science published by Wiley-","cbCaiuI6Gyy9JS4k","https://ap.wps.com/l/cbCaiuI6Gyy9JS4k","pdf",5742611,16,"English","# Introduction\n## Ferroptosis and its therapeutic potential\n## Tumor heterogeneity in ferroptosis sensitivity\n## Patient-derived organoids (PDOs)\n## Mitochondrial homeostasis and mitophagy defects","[{\"question\":\"What model was used to identify ferroptosis-sensitive colorectal tumors?\",\"answer\":\"Patient-derived organoid (PDO) screening models based on colorectal cancer tissues were established to identify tumors sensitive to ferroptosis-inducing therapy.\"},{\"question\":\"How does mitophagy deficiency affect ferroptosis sensitivity?\",\"answer\":\"Mitophagy-deficient tumors are hypersensitive to ferroptosis-inducing therapies because they lack an anti-ferroptotic mechanism that normally restrains lipid peroxidation and mitochondrial ROS accumulation.\"},{\"question\":\"Which therapies were reported to trigger ferroptotic cell death in mitophagy-deficient tumors?\",\"answer\":\"Ferroptosis-inducing triggers include erastin, RSL3, cysteine deprivation, radiotherapy, and immunotherapy, which produce potent ferroptotic cell death in mitophagy-deficient tumors.\"}]","Susceptibility of Mitophagy-Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid Peroxidation | PDF",1790053340,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4fe4fec95725b68f2b38ced531530ce.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/262f34a998483bc51dd7fd1016cf748b.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f197596a761b153dfdd4bba61ca2db65.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14f7d9d6b60cd898822be2f3a4de6e1f.webp",980,1287]